The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on April 16 to Boehringer Ingelheim Pharmaceuticals at its 2011 Annual Conference, April 13-16 at the Gaylord National. The AMGA Distinguished Corporate Partner Award is presented annually to a non-medical group organization for providing excellent service and value to medical groups and their patients.
Boehringer Ingelheim Pharmaceuticals was chosen to receive the 2011 AMGA Distinguished Corporate Partner Award because of its strong and continual support of the association, its programs, and its members. In particular, AMGA recognized the organization's support of the Managing Chronic Obstructive Pulmonary Disease Learning Collaborative. The learning collaborative supports improvements in chronic care management systems that focus on improving the care of patients with COPD across all care settings, offering a learning environment where participants can exchange strategies and experiences, test approaches, and design care processes that are relevant to their clinical and operational models. The program has a direct benefit to patients and their families and promotes the development and dissemination of best practices in caring for this debilitating disease.
"The American Medical Group Association applauds Boehringer Ingelheim for its unwavering dedication to healthcare professionals and the practice of quality medicine in this country and worldwide," said Donald W. Fisher, Ph.D., CAE, AMGA's President and Chief Executive Officer. "Their support has enabled us to provide invaluable resources and educational and networking forums for healthcare professionals. We look forward to their future contributions to the work of AMGA members as they quest to improve the delivery of quality patient care."
Remote interpreting raises concerns about communication quality in healthcare